Arena Stock Quick Win by the Algorithm: Bullish Outperformance by ARNA

Quick Win by the Algorithm:

On July 3rd, 2017, the I Know First algorithm issued a bullish 14-day forecast for Arena Pharmaceuticals (NASDAQ:ARNA), with a signal of 44.27 and a predictability of 0.23. As a result, in accordance with the forecast, the company’s stock produced a return of 42.62% over this period, solidifying another quick win by the I Know First algorithm.
Arena Stock

Arena Pharmaceuticals is a an American, San Diego, California-based biopharmaceutical company founded in 1997. The company is currently researching and developing small molecule drugs for possible clinical utility in multiple therapeutic areas. Specifically, ARNA focuses on discovering drugs that act on G protein-coupled receptors (GPCRs); the largest and most diverse group of protein receptors that act like an inbox for cellular chemical messages. ARNA has six separate compounds currently moving through clinical trials. ARNA has three partnered programs, and currently offers one on the market worldwide.


Best Biotech Stocks

The major cause of outperformance was ARNA reporting positive top-line mid-stage Phase 2 trial results for Ralinepag. This treatment is for patients with Pulmonary Arterial Hypertension. This is significant for two reasons. Firstly, whenever any biopharmaceutical company announces positive clinical trial data and results, this is a major bullish indicator for the company since it hints at a potential tailwind of profitability if the clinical trials keep going positively. Secondly, Pulmonary Arterial Hypertension is a type of high blood pressure that occurs in the right side of your heart and in the arteries that supply blood to your lungs. This condition is a rare disease for which there is presently no cure. Therefore, should ARNA be successful in bringing this drug to market, it will have a monopoly on this treatment.

Current I Know First subscribers received this bullish ARNA forecast on July 3rd, 2017. 

Before making any trading decisions, consult the latest forecast as the algorithm updates predictions daily. You can use the algorithm for intra-day trading. The predictability tends to become stronger with forecasts over longer time-horizons such as the 1-month, 3-month and 1-year forecasts.